Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed (vol 38, pg 4821, 2022)

被引：0

作者：

Citrome, Leslie ^{[1
]}

Risinger, Robert ^{[2
]}

Rajachandran, Lavanya ^{[2
]}

Robison, Heather ^{[2
]}

机构：

[1] New York Med Coll, Dept Psychiat & Behav Sci, Valhalla, NY USA

[2] BioXcel Therapeut Inc, 555 Long Wharf Dr, New Haven, CT USA

来源：

ADVANCES IN THERAPY | 2023年 / 40卷 / 01期

关键词：

D O I：

10.1007/s12325-022-02350-8

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：391 / 391

页数：1

共 38 条

[1] Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
Citrome, Leslie
Risinger, Robert
Rajachandran, Lavanya
Robison, Heather
ADVANCES IN THERAPY, 2022, 39 (10) : 4821 - 4835
[2] Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
Leslie Citrome
Robert Risinger
Lavanya Rajachandran
Heather Robison
Advances in Therapy, 2022, 39 : 4821 - 4835
[3] Correction to: Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
Leslie Citrome
Robert Risinger
Lavanya Rajachandran
Heather Robison
Advances in Therapy, 2023, 40 : 391 - 391
[4] Cariprazine for bipolar depression: What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome, Leslie
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2019, 73 (10)
[5] DARIDOREXANT IN PATIENTS WITH INSOMNIA DISORDER: NUMBER NEEDED TO TREAT, NUMBER NEEDED TO HARM & LIKELIHOOD TO BE HELPED OR HARMED
Chalet, Francois-Xavier
Luyet, Pierre-Philippe
Rabasa, Cristina
Vaillant, Cedric
Saskin, Paul
Ahuja, Ajay
Citrome, Leslie
SLEEP, 2023, 46 : A155 - A155
[6] Lumateperone for the Treatment of Schizophrenia: Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed br br
Citrome, Leslie
Durgam, Suresh
Edwards, John B.
Davis, Robert E.
JOURNAL OF CLINICAL PSYCHIATRY, 2023, 84 (02)
[7] Daridorexant for patients with chronic insomnia disorder: number needed to treat, number needed to harm, and likelihood to be helped or harmed
Chalet, Francois-Xavier
Luyet, Pierre-Philippe
Rabasa, Cristina
Vaillant, Cedric
Saskin, Paul
Ahuja, Ajay
Citrome, Leslie
POSTGRADUATE MEDICINE, 2024, 136 (04) : 396 - 405
[8] Adjunctive Aripiprazole, Olanzapine, or Quetiapine for Major Depressive Disorder: An Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
Citrome, Leslie
POSTGRADUATE MEDICINE, 2010, 122 (04) : 39 - 48
[9] Lumateperone in Pooled Late-Phase Schizophrenia Trials: Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed
Citrome, Leslie
Durgam, Suresh
Edwards, John B.
Davis, Robert E.
CNS SPECTRUMS, 2023, 28 (02) : 244 - 244
[10] TEM Number Needed to Treat and Number Needed to Harm From Two Phase 3 Studies of Sublingual Dexmedetomidine for Treating Acute Agitation in Patients With Schizophrenia and Bipolar Disorder
Citrome, L.
Risinger, R.
Rajachandran, L.
Patton, E.
Robison, H.
CNS SPECTRUMS, 2023, 28 (02) : 227 - 227

← 1 2 3 4 →